Premium Market Analysis, Trader Education, Software, and Trading Strategies

Trading Strategies

Trading Strategy For Dow 30 Stocks

This is a simple strategy for trading Dow 30 stocks with no parameters to optimize and no filters. The strategy has outperformed SPY ETF annualized return since inception by a wide margin and has a Sharpe of more than 1. Updated: January 6, 2023.

For all backtests in this article we used Norgate data for Dow 30 index that includes current and past constituents. We highly recommend this data service (we do not have a referral arrangement with the company.)

Click here for more details
Backtest settings

Timeframe: Daily (adjusted data)
Index: Dow 30  (current and past constituents)
Strategy type: Long-only mean-reversion
Maximum open positions: 10
Position size:  equity/10
Commission: $0.005/share
All trades are executed at the open of the next bar
Backtest range: 01/02/1993 –12/30/2022

Comments

  • The backtest starts in 1993 to allow a sufficient sample.
  • The strategy has no parameters and no price action filers.

Equity curve, yearly returns, drawdown profile, and comparison to S&P 500 total return B&H

Performance Summary

STRATEGY SPY BUY AND HOLD
CAGR 17.6% 9.5%
MDD -30.5% -55.2%
SHARPE 1.01 0.50
MAR (CAGR/MDD) 0.58 0.18
TRADES 10,723
WIN RATE 65.6%
AVG. BARS IN TRADE 6.9
EXPOSURE 40.5% 100%

The strategy CAGR is 17.6% versus 9.5% for buy and hold (without dividends). The maximum drawdown of the strategy is -30.5% versus -55.2% for buy and hold. The Sharpe of the strategy is 1.10 versus 0.52 for buy and hold.

The average holding period is 6.9 days and exposure is 41%. The strategy has generated more than 10,000 trades in the test period.

In 2022 the strategy gained 6.7%versus a loss of 18.5% for SPY ETF.

The rules of this strategy are available separately or as part of a bundle of six strategies. Contact us for more details and price. Instructions for unlocking the restricted content below are emailed after payment is received.

Click here for a list of strategies. 

Disclaimer:  No part of the analysis in this blog constitutes a trade recommendation. The past performance of any trading system or methodology is not necessarily indicative of future results. Read the full disclaimer here.

Charting and backtesting program: Amibroker. Data provider: Norgate Data

If you found this article interesting, you may follow this blog via RSSEmail, or  Twitter

Disclaimer